Diluted HEPS from continuing operations of 152.2 cps (1H23: 97.5 cps).
Revenue up by +2.5% y-y (1H23: -0.7% y-y).
EBITDA margin down to 22.1% (1H23: 22.5%).
Operating margin up from 5.6% LY to 9.1% in 1H24 due to reduction in depreciation and amortisation.
Expense to sales at 80.4% (1H23: 80.1%).
No dividend (1H23: nil).
